BioMarin Pharmaceutical I... (BMRN)
NASDAQ: BMRN
· Real-Time Price · USD
57.51
-0.49 (-0.84%)
At close: Aug 15, 2025, 3:59 PM
58.59
1.89%
After-hours: Aug 15, 2025, 07:22 PM EDT
BioMarin Pharmaceutical Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 426.22M | n/a | 124.94M | 106.08M | 107.17M | 88.66M | 20.38M | 40.38M | 56.04M | 50.85M | -249K | -6.65M | 27.66M | 120.8M | -57.9M | -36.49M | 12.94M | 17.37M |
Depreciation & Amortization | 18.56M | 22.07M | 23.61M | 19.01M | 26.46M | 27.35M | 26.86M | 25.68M | 25.42M | 26.42M | 24.55M | 24.8M | 25.27M | 27.34M | 25.99M | 26.84M | 27.23M | 27.98M |
Stock-Based Compensation | 47.53M | 37.7M | 52.86M | 43.49M | 47.91M | 58.25M | 54.85M | 48.39M | 50.16M | 53.7M | 46.73M | 54.66M | 47.08M | 47.83M | 43.89M | 49.03M | 54.84M | 49.5M |
Other Working Capital | n/a | -5.88M | -21.17M | 91.71B | 11.62M | -26.17M | 7.97M | -13.93M | -19.88M | -32.06M | -5.43M | 4.76M | 78.58M | -4.86M | 15.76M | 1.8B | 1.91B | 46.7M |
Other Non-Cash Items | -340.38M | 86.2M | 24.98M | -131.57M | 182.26M | 169.97M | 261.01M | 42.22M | 143.71M | 309.22M | 236K | -1.82M | -4.37M | -109.51M | 2.9M | 2.92M | 18K | 7.05M |
Deferred Income Tax | 33.34M | 28.43M | 42.39M | 12.17M | 1.25M | 285K | -24.84M | -15.03M | 1.25M | -6.36M | -51.34M | -4.2M | -1.34M | 4.8M | -3.59M | -13.22M | -2.13M | 3.33M |
Change in Working Capital | n/a | -90.46M | -83.15M | 172.31M | -66.92M | -105.39M | -97.12M | 39.92M | -62.7M | -216.64M | -13.14M | 91.53M | -38.07M | -136.69M | -116K | 68M | -10.12M | 8.27M |
Operating Cash Flow | 185.27M | 174.39M | 185.63M | 221.48M | 118.76M | 46.97M | 27.48M | 135.65M | 70.06M | -73.93M | 6.79M | 158.32M | 56.23M | -45.43M | 11.18M | 97.06M | 82.78M | 113.51M |
Capital Expenditures | -17.1M | -16.77M | -20.3M | -21.18M | -21.84M | -34.1M | -36.7M | -23.42M | -22.73M | -24.77M | -36.36M | -36.47M | -28.04M | -30.68M | -44.36M | -20.36M | -26.25M | -28.25M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 24.06M | -51.11M | 5.56M | n/a | -5.9M | 2.54M | n/a | 15.62M | -1.63M | 3.65M | 2.75M |
Purchase of Investments | -113.16M | -89.27M | -57.88M | -156.91M | -73.8M | -121.67M | -141.45M | -282.99M | -223.69M | -220.36M | -154.43M | -152.58M | -157.44M | -147.36M | -200M | -252.57M | -247.4M | -237.17M |
Sales Maturities Of Investments | 117.93M | 77.8M | 154.58M | 160.79M | 186.12M | 131.53M | 113.19M | 260.61M | 275.94M | 215.12M | 142.75M | 165.65M | 155.78M | 155.82M | 188.94M | 153.17M | 154.3M | 194.64M |
Other Investing Acitivies | -266K | n/a | -769K | -1.57M | 111.81M | 10M | n/a | -24.06M | 51.11M | -5.56M | -6.67M | 5.9M | -2.54M | 110M | -15.62M | 1.54M | -4.56M | -2.75M |
Investing Cash Flow | -12.59M | -28.24M | 76.4M | -16.16M | 90.48M | -14.24M | -64.96M | -45.8M | 29.53M | -30.01M | -54.71M | -23.4M | -29.7M | 87.78M | -55.42M | -119.85M | -120.26M | -70.79M |
Debt Repayment | n/a | n/a | n/a | -494.93M | -18K | -42K | -45K | -606K | -621K | -1.01M | -970K | -513K | -556K | -566K | -547K | -551K | -857K | -1.08M |
Common Stock Repurchased | n/a | n/a | -4.91M | n/a | -16.79M | -49.95M | -3.92M | -4.54M | -16.44M | -51.42M | -3.59M | -6.32M | -11.43M | -32.95M | -1.38M | -5.7M | -9.63M | -29.1M |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -4.6M | -38.78M | 7.66M | -8.99M | 12.63M | -42.75M | 10.88M | -182K | 12.58M | -39.73M | 11.84M | 8.05M | -11.22M | -24.71M | 14.94M | -480K | 11.81M | -23.28M |
Financial Cash Flow | -4.6M | -38.78M | 2.86M | -499.13M | 12.61M | -42.79M | 10.84M | -788K | 11.96M | -40.74M | 10.87M | 7.54M | -11.78M | -25.28M | 14.4M | -1.03M | 10.95M | -24.36M |
Net Cash Flow | n/a | 105.96M | 267.39M | -296.7M | 225.15M | -8.13M | -30.29M | 91.03M | 114.31M | -144.46M | -36.98M | 141.71M | 14.36M | 18.16M | -29.87M | -24.39M | -25.78M | 18.16M |
Free Cash Flow | 168.17M | 157.63M | 165.33M | 200.31M | 96.92M | 12.87M | -9.21M | 112.23M | 47.33M | -98.7M | -29.57M | 121.85M | 28.19M | -76.11M | -33.18M | 76.7M | 56.53M | 85.26M |